Upcoming Conferences in the Life Sciences Industry

The Dutch Life Sciences Conference is the Netherlands most established life sciences event. It has positioned itself as the premier annual meeting place for both Dutch and international players. The event brings together leading CEOs of biotech, pharma and medical devices companies, heads of R&D, academics, and life sciences investors from the healthcare sector for networking opportunities to promote the translation of inventions into e.g. therapies, medical devices and diagnostics distribution in and across the healthcare system. It provides a unique opportunity for discussions, panel presentations and product demonstrations and to meet new companies, paving the way for new business collaborations.

In-Person Day 7 December 2023, Online Innovation Workshops 4, 5, 6 December 2023.

The annual Genesis conference has been a pillar of the Life Science sector for over two decades. Bringing together key opinion leaders, investors and innovators from across the sector to share insight, debate key trends and generate deals.

We expect 2023 to be no different! Under a headline theme of Maximising Returns from Life Science Innovation the event will feature:

High content mix of keynote talks and panel discussions from key opinion leaders.
Networking with 300 delegates on the day.
Option to arrange 1 to 1 meetings with delegates via the event app.
Genesis Fringe events for informal in-person networking.
Digital Innovation Workshops in the lead-up to the in-person Genesis conference for technical and business insights.
Exhibition for invaluable innovation support from our network.
Delegate rates from only £325 +VAT.
Sponsorship opportunities from £5K + VAT.
Exhibitor opportunities from £500 + VAT.

Remaining in the prestigious and easily accessible 1 Wimpole Street venue in Central London, fittingly the home of the Royal Society of Medicine, Genesis 2023 is set to deliver a fantastic opportunity for the ecosystem to connect, collaborate and create return for innovators, investors, patients and society.

Follow us on Twitter @OneNucleus using #GenesisLondon23.

You can find a list of companies that attended Genesis 2022 here: https://www.genesisconference.com/attending-companies

Join us for "JPM Week for Service Providers: Standing Out in a Crowded Field," a transformative webinar designed to empower service providers like you with the knowledge and strategies needed to shine during JPM Week 2024. This webinar is your exclusive opportunity to maximize your impact and engagement during JPM Week 2024. Whether you're a seasoned service provider or new to the JPM experience, this event will equip you with the tools and strategies needed to succeed in a competitive and fast-paced environment.

With the highest attending rate of TTOs, research institutes and academia together with big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.

BioFIT takes place on-site December 12-13, with online partnering on December 15.

We are pleased to announce that the 7th Annual Neuroscience Innovation Forum (#Sachs_NIF) will take place at the Marines Memorial Club, San Francisco on the 7th of January 2024, a day before the JP Morgan meeting and the Virtual Week will take place the week after, from the 16th - 18th of January.

The forum, positioned at the beginning of JPM week, focuses on the latest developments across key areas of Neuroscience which are currently drawing widespread investor interest. The main programme for the 7th Annual NIF will feature more than 8 hours of high-level keynotes and panel discussions addressing the important advances in therapeutic, neurotech and diagnostics fields.

Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering them a unique opportunity to showcase their innovations and engage one-to-one with investors and biopharmaceutical executives.

The 42nd Annual Healthcare Conference will take place on January 8-11, 2024 in San Francisco, CA.

This premier conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community.

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain, connecting start-ups with 10 categories of global investors across the silos of drugs, devices, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups, those seeking grants, seed and angel capital, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Biotechgate Digital Partnering is a virtual conference designed to support the business development of Biotech, Medtech and Pharma companies. Join five days of digital partnering and establish new global connections thanks to pre-arranged one-on-one Zoom meetings, along with informal networking events and workshops.

Participate in one of the largest investor conferences in our industry where institutional investors, industry analysts, and senior executives are shaping the future investment landscape of biotechnology.

Don't miss your opportunity to:

Find and request meetings with potential partners using the BIO One-on-One Partnering™ system

Discover the latest innovations in biotech during Company Presentations

Hear from thought-leaders during sessions on therapeutic advancements, market outlook, and policy priorities

We are pleased to announce that the 17th Annual European Life Sciences CEO Forum (Sachs_ELSF) will take place on the 28th - 29th February 2024 back at the Hilton Zurich Airport Hotel. The event will be part of the Sachs Spring Life Sciences Week, which will also incorporate the 5th Annual European HealthTech CEO Forum.

The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2024. The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 6th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.

The main programme for the 17th Annual ELSF is spread throughout 2 days (28th - 29th of February) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks and advisors with part of the audience participating virtually.

The eighteenth annual BIO-Europe Spring® conference is back in-person and will be taking place from 18 to 20 March 2024 in Barcelona, Spain

Building and nurturing relationships is an essential part of the progression of successful business partnerships. BIO-Europe Spring 2024 will offer a fusion of innovative digital solutions and a vibrant on-site event of unprecedented scope.

Expanding on the success of EBD Group’s flagship conference, BIO-Europe® , BIO-Europe Spring will bring together over 3,700 leading executives from around the world. Specifically, we will host more than 20,000 partnering meetings to connect leaders from academia, start-up, and scale-up biotech companies with forward-thinking investors and pharma companies. Along with world-class workshops and panels, innovative company presentations, active exhibition and a variety of networking opportunities make this event an unrivalled forum for companies across the biotech value chain to meet and do business.

A methodology for assessing the risk profile of a life science company prior to valuation.

The different valuation methods used for life science companies and products.

How to calculate the value of a biotech or life science company with the Discounted Cash Flow method, comparables and exit valuation.

How to use risk-adjusted Net Present Value (rNPV) to calculate the value of a pharmaceutical compound in development.

How to structure the licensing deal between companies, covering issues such as milestone and royalty payments.

The Swiss Biotech Day is a premier biotechnology conference in Europe, attracting professionals from the global life sciences community. In 2024, it will once again provide a platform for networking, engaging discussions, and the exploration of advancements in R&D, manufacturing, data management, artificial intelligence, and innovative financing. International biotech delegations use the “Global Village” to strengthen their ties with Switzerland as a biotech hub and promote cross-border investments, public-private partnerships, research and development collaborations and exchange of talent.